|0.7350||+0.1180||+19.12%||Vol 331.10K||1Y Perf -85.02%|
|Jun 27th, 2022 16:00 DELAYED|
|- -||0.00 0.54%|
|Target Price||10.40||Analyst Rating||Strong Buy 1.00|
|Potential %||1.31K||Finscreener Ranking||★★ 45.77|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★ 39.49|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★ 34.74|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||3.87||Earnings Rating||Strong Buy|
|Market Cap||37.29M||Earnings Date||16th May 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.42|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||401.77K|
|Avg. Monthly Volume||242.14K|
|Avg. Quarterly Volume||482.42K|
Applied Genetic Technologies Corporation (NASDAQ: AGTC) stock closed at 0.735 per share at the end of the most recent trading day (a 19.12% change compared to the prior day closing price) with a volume of 331.10K shares and market capitalization of 37.29M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Applied Genetic Technologies Corporation CEO is Susan B. Washer.
The one-year performance of Applied Genetic Technologies Corporation stock is -85.02%, while year-to-date (YTD) performance is -61.32%. AGTC stock has a five-year performance of -85.87%. Its 52-week range is between 0.58 and 4.59, which gives AGTC stock a 52-week price range ratio of 3.87%
Applied Genetic Technologies Corporation currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.67, a price-to-sale (PS) ratio of 74.58, a price to cashflow ratio of 1.80, a PEG ratio of 2.32, a ROA of -59.81%, a ROC of -65.79% and a ROE of -90.45%. The company’s profit margin is -80.91%, its EBITDA margin is -12 147.80%, and its revenue ttm is $500.00 Thousand , which makes it $0.01 revenue per share.
Of the last four earnings reports from Applied Genetic Technologies Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.42 for the next earnings report. Applied Genetic Technologies Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Applied Genetic Technologies Corporation is Strong Buy (1), with a target price of $10.4, which is +1 314.97% compared to the current price. The earnings rating for Applied Genetic Technologies Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Applied Genetic Technologies Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Applied Genetic Technologies Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 14.93, ATR14 : 0.09, CCI20 : -231.52, Chaikin Money Flow : -0.11, MACD : -0.04, Money Flow Index : 47.52, ROC : -32.20, RSI : 28.33, STOCH (14,3) : 10.00, STOCH RSI : 0.00, UO : 40.88, Williams %R : -90.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Applied Genetic Technologies Corporation in the last 12-months were: Gerald Anthony Reynolds (Sold 3 994 shares of value $3 376 ), Susan B. Washer (Option Excercise at a value of $55 810), Susan B. Washer (Sold 9 950 shares of value $21 691 )
Mon, 14 Feb 2022 16:50 GMT Applied Genetic Technologies (AGTC) Gets a Buy Rating from H.C. Wainwright- TipRanks. All rights reserved.
Fri, 14 Jan 2022 09:11 GMT Applied Genetic Technologies (AGTC) Receives a Buy from Wells Fargo- TipRanks. All rights reserved.
Tue, 11 Jan 2022 16:05 GMT Applied Genetic Technologies (AGTC) Receives a Buy from H.C. Wainwright- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.